These colon cancer cells were subjected to various treatments, including individual exposures to COS (5 μM) and IFN-γ (20 ng/mL), as well as cotreatments involving Jurkat T cells at ratios of 1:10 and 1:20. This evidence concerns the gene IFNG and colonic neoplasm.